Evolent Health, Inc. (EVH) is a publicly traded company in the Unknown sector. Across all available filings, 37 corporate insiders have executed 546 transactions totaling $837.3M, demonstrating a bearish sentiment with -$835.6M in net insider flow. The most recent transaction on Nov 18, 2025 involved a purchase of 10,000 shares valued at $38.2K.
No significant insider buying has been recorded for EVH in the recent period.
No significant insider selling has been recorded for EVH in the recent period.
Based on recent SEC filings, insider sentiment for EVH is bearish with an Insider Alignment Score of 0/100 and a net flow of -$835.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Evolent Health, Inc. (EVH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 37 insiders are actively trading EVH stock, having executed 546 transactions in the past 90 days. The most active insider is James G. Coulter (Executive), who has made 6 transactions totaling $234.4M.
Get notified when executives and directors at EVH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | B. Springstubb Brendan | Executive | Purchase | 10,000 | $3.82 | $38.2K | |
| Aug 1, 2025 | Shams Aammaad | Executive | Payment | 2,567 | $9.98 | $25.6K | |
| Jul 1, 2025 | Paul Johnson John | Executive | Award | 25,461 | $N/A | $0 | |
| Jul 1, 2025 | Joseph Mccarthy Daniel | Executive | Award | 44,767 | $N/A | $0 | |
| Jul 1, 2025 | Weinberg Jonathan | Executive | Award | 23,394 | $N/A | $0 | |
| Jul 1, 2025 | Blackley Seth | Executive | Award | 67,150 | $N/A | $0 | |
| Aug 23, 2024 | Joseph Mccarthy Daniel | Executive | Sale | 4,000 | $33.00 | $132.0K | 10b5-1 |
| Aug 23, 2024 | Joseph Mccarthy Daniel | Executive | Sale | 6,469 | $32.00 | $207.0K | 10b5-1 |
| Aug 22, 2024 | Ann Rafferty Emily | Executive | Sale | 8,861 | $30.00 | $265.8K | 10b5-1 |
| Aug 22, 2024 | Paul Johnson John | Executive | Sale | 44,693 | $30.00 | $1.3M | Large10b5-1 |
| Aug 22, 2024 | Blackley Seth | Executive | Sale | 187,904 | $30.00 | $5.6M | Large10b5-1 |
| Aug 22, 2024 | Blackley Seth | Executive | Option Exercise | 52,742 | $10.27 | $541.7K | Large10b5-1 |
| Aug 22, 2024 | Blackley Seth | Executive | Option Exercise | 35,162 | $10.27 | $361.1K | 10b5-1 |
| Aug 22, 2024 | Blackley Seth | Executive | Option Exercise | 100,000 | $6.87 | $687.0K | Large10b5-1 |
| Aug 22, 2024 | Weinberg Jonathan | Executive | Option Exercise | 16,887 | $17.00 | $287.1K | 10b5-1 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 244 | $836.5M | 95.6% |
Payment(F) | 46 | $23.5M | 2.7% |
Exercise(M) | 98 | $13.8M | 1.6% |
Purchase(P) | 8 | $851.7K | 0.1% |
Award(A) | 137 | $0 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Conversion(C) | 10 | $0 | 0.0% |
Insider selling pressure at Evolent Health, Inc. has increased, with 37 insiders executing 546 transactions across all time. Total sales of $836.5M significantly outpace purchases of $851.7K, resulting in a net outflow of $835.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.